Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PHYKPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TBC1D22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF568 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDHD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMYD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMNTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM209B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on